Advert - GlaxoSmithKline

• Date posted
  12 March 2021
• Sanction
  Advertisement,
• Case number/s
  AUTH/3308/2/20 - Anonymous/Director v GlaxoSmithKline

For a webinar registration page which promoted Relvar (fluticasone/vilanterol) but failed to comply with an undertaking in a previous case, GlaxoSmithKline was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 4.1 - Failing to include up-to-date prescribing information

Clauses 4.4 - Failing to provide prescribing information in digital material

Clause 4.6 - Failing to include a clear, prominent statement as to where prescribing information could be found

Clause 9.1 - Failing to maintain high standards

Clause 29 - Failing to comply with an undertaking